Below you can find a list of projects that involve members of the Radiomics Group.
Instituto de Salud Carlos III. “Deciphering colon cancer heterogeneity with machine learning and precision imaging”. Duration: 2022-2025.
Fundación Científica Asociación Española Contra el Cáncer-Proyectos Coordinados. “Tumoral senescence induced by anti-cancer therapiesconstitutes a novel prognostic biomarker and a therapeutic target”. Duration: 2021-2026.
Horizon 2020 Program-European Commission. “DART: Building Data Rich Clinical Trials”. Duration: 2021-2026.
CRIS Cancer Foundation. “Personalized response Imaging biomarker for Cancer immunotherapy”. Duration: 2020-2025.
Fundación La Marató de TV3. “PrecIMet: precision imaging for bone metastases”. Duration: 2020-2023.
Fundación FERO. “Unraveling the tumor immunophenotype with deep-learning based radiogenomics”. Duration: 2020-2022.
Prostate Cancer Foundation. “A two-stage study to clinically qualify whole-body diffusion-weighted MRI in patients with metastatic castration resistant prostate carcinoma with bone metastases”. Duration: 2018-2022.
Instituto de Salud Carlos III. “Estudio de validación clínica de la resonancia de cuerpo completo con difusión en pacientes con cáncer de próstata resistente a la castración y metástasis ósea”. Duration: 2019-2022.
Horizon 2020 Innovative Medicine Initiative. “Immune-Image: Specific Imaging of Immune Cell Dynamics Using Novel Tracer Strategies”. Duration: 2019-2024.
2022 “la Caixa” Foundation Junior Leader Fellowship (Retaining). “New-generation oncological MRI (New-OncoMRI): development, validation and application”. Fellow: Francesco Grussu. Duration: 09/2022-09/2025.
2020 Beatriu de Pinós post-doctoral fellowship. “Advancing Magnetic Resonance Imaging against liver cancer”. Fellow: Francesco Grussu. Duration: 01/2022-12/2024 (renounced on 09/2022).
2021 INPhINIT La Caixa Retaining Pre-doctoral fellowship. PhD in Biomedical Engineering (Universitat Politècnica de Catalunya). Fellow: Olivia Prior. Duration: 12/2021-12/2024.
2020 PERIS pre-doctoral fellowship. “Precision Medicine and Artificial Intelligence for characterizing cancer response to immunotherapy”. Fellow: Marta Ligero. Duration: 01/2021-12/2024.
2019 Beatriu de Pinós post-doctoral fellowship. “Improving patient Selection for immunotherapy: Multi-Omics signature for Response Evaluation (ISeeMORE)”. Fellow: Kinga Bernatowicz. Duration: 10/2020-09/2023.
European Commission-funded ATTRACT program. “Detection of genetic abnormalities using persistent homology in radiomics”. Duration: 2019-2020.
USA Department of Defense Impact Award. “Clinical Qualification of DNA Repair Defects as Biomarkers in Metastatic Prostate Cancer Using Integrated Genomics and Tissue-Based Functional Assays”.